Author name: Kiran George

SpicyIP Highlight of the Week ! Our Highlight of the week was definitely Balaji’s post, where he delved into the recent controversy surrounding the Government’s alleged ‘private reassurances’ to the US-India Business Council that it would not invoke commercial licensing for commercial purposes. He notes that while the government’s long over-due press release, where it explicitly denounces the reports making the said allegations as being factually incorrect, is certainly welcome, he ponders over whether there is more than what meets

SPICYIP HIGHLIGHT In a fantastic two-part follow-up to Part I of his series on Specialised IP Courts, Shamnad sir critically examines the functioning of specialised IP tribunals in India. In Part II, he thoroughly explores various nuances of the IPAB’s working and operation since it came into existence more than a decade ago, and its performance thus far, on four substantial counts – its constitutional competence, its pendency rates and its possible – although debatable – institutional bias. In Part

Our SpicyIP Highlight of the Week was definitely Balaji’s post breaking the news of the IPO’s rejection of Lee Pharma’s application for a Compulsory License against AstraZeneca’s patent for the anti-diabetic drug Saxagliptin (see here). He notes that the rejection signals the end of the third compulsory license application in India, after Natco v. Bayer and BDR v. BMS. He goes on to discuss the details of the order in his next post. Next, Shruthi announced the commencement of the